CK Life Sciences Int'l (Holdings) Inc - Company Profile
Powered by 
All the data and insights you need on CK Life Sciences Int'l (Holdings) Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date CK Life Sciences Int'l (Holdings) Inc Strategy Report
- Understand CK Life Sciences Int'l (Holdings) Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
CK Life Sciences Int'l (Holdings) Inc (CK Life), a subsidiary of CK Hutchison Holdings Limited, is an investment holding company that conducts research and development, commercialization, marketing, and sale of pharmaceutical and agriculture-related products. It offers products related to human health and environmental sustainability. CK Life produces eco-fertilizer products and nutritional supplements. The company also develops products for cancer, health supplements, natural healthcare products, fertilizer products and crop protection products. The company has operations in Australia, Canada, New Zealand, China, Hong Kong, the US, and Virgin Islands, among others. CK Life is headquartered in Hong Kong City, Hong Kong.
Headquarters
Hong Kong
Address
2 Dai Fu Street, Tai Po Industrial Estate, Hong Kong
Website
www.ck-lifesciences.com
Telephone
852 21261212
No of Employees
1,932
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
775 (HKG)
Revenue (2022)
$679.9M
0.9%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-86.9%
(2022 vs 2021)
Market Cap*
$423.4M
Net Profit Margin (2022)
XYZ
-87.2%
(2022 vs 2021)
* As of and is in US$
CK Life Sciences Int'l (Holdings) Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Nutraceuticals | Halneuron |
| Pharmaceuticals | |
| Agricultural Products - Fertilizers |
Competitor Comparison
| Key Parameters | CK Life Sciences Int'l (Holdings) Inc | Shanghai Pharmaceuticals Holding Co Ltd | Nanjing Pharmaceutical Co Ltd | China Medical System Holdings Ltd | China Shineway Pharmaceutical Group Ltd |
|---|---|---|---|---|---|
| Headquarters | Hong Kong | China | China | Hong Kong | China |
| City | Hong Kong | Shanghai | Nanjing | Hong Kong | Shijiazhuang |
| State/Province | - | Shanghai | Jiangsu | Guangdong | Hebei |
| No. of Employees | 1,932 | 48,164 | 4,903 | 5,701 | 3,533 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| LI Tzar Kuoi Victor | Chairman | Executive Board | 2002 | 58 |
| YU Ying Choi, Alan Abel | Director; Vice President; Chief Executive Officer | Executive Board | 2020 | 67 |
| Ip Tak Chuen Edmond | Director; Chief Investment Officer; Senior Vice President | Executive Board | 2021 | 70 |
| MO Yiu Leung, Jerry | Chief Financial Officer | Senior Management | - | 62 |
| Toh Kean Meng, Melvin | Chief Scientific Officer; Vice President - Pharmaceutical Development | Senior Management | 2021 | 56 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer